Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular versus intravenous tranexamic acid in total knee arthroplasty
IRCT20160809029286N3Phase 3Completed
- Sponsor
- Joint Reconstruction Research Center
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tranexamic acid in Bleeding (2 arms), sponsored by Joint Reconstruction Research Center. Primary endpoints: Total perioperative blood loss, Pre-operative hemoglobin and 1 more. Started Jul 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on IRCT20160809029286N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160809029286N3.